Stockscreener 앱 받기
7.79
0.26%
-0.02
시장 영업 전:
7.73
-0.06
-0.77%
전일 마감가:
$7.81
열려 있는:
$7.86
하루 거래량:
133.30K
Relative Volume:
0.76
시가총액:
$291.86M
수익:
$128.45M
순이익/손실:
$6.54M
주가수익비율:
155.80
EPS:
0.05
순현금흐름:
$-8.79M
1주 성능:
+2.10%
1개월 성능:
-5.23%
6개월 성능:
+14.06%
1년 성능:
+2.77%
1일 변동 폭
$7.76
$7.93
1주일 범위
$7.34
$7.93
52주 변동 폭
$4.76
$8.85
Lifecore Biomedical Inc Stock (LFCR) Company Profile
명칭
Lifecore Biomedical Inc
전화
(952) 368-4300
주소
3515 LYMAN BOULEVARD, CHASKA
LFCR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LFCR
Lifecore Biomedical Inc
|
7.79 | 292.61M | 128.45M | 6.54M | -8.79M | 0.05 |
|
ZTS
Zoetis Inc
|
118.66 | 51.85B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.33 | 45.46B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.52 | 42.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.79 | 34.62B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
493.99 | 21.03B | 3.08B | 1.24B | 1.07B | 25.61 |
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-04 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2025-05-21 | 개시 | William Blair | Outperform |
| 2024-09-05 | 개시 | Craig Hallum | Buy |
| 2024-08-28 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2023-03-20 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
Lifecore Biomedical Inc 주식(LFCR)의 최신 뉴스
Understanding the Setup: (LFCR) and Scalable Risk - news.stocktradersdaily.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Reach Out - ACCESS Newswire
What analysts say about Lifecore Biomedical Inc LDE stockFederal Reserve Announcements & Outperform the Market with Aggressive Picks - earlytimes.in
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Is Lifecore Biomedical Inc a good long term investmentMarket Sentiment Report & High Yield Stock Picks - earlytimes.in
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Halper Sadeh LLC Encourages Lifecore Biomedical, Inc. Shareholders to Contact the Firm to Discuss Their Rights - The AI Journal
Will Lifecore Biomedical Inc. (LDE) stock see insider accumulationWeekly Risk Report & Community Consensus Trade Signals - Newser
Will Lifecore Biomedical Inc. (LDE) stock attract long term capital inflowsWall Street Watch & Accurate Entry/Exit Alerts - Newser
The Technical Signals Behind (LFCR) That Institutions Follow - news.stocktradersdaily.com
Will Lifecore Biomedical Inc. (LDE) stock split increase liquidityMarket Risk Summary & Reliable Intraday Trade Alerts - Newser
Will Lifecore Biomedical Inc. (LDE) stock benefit from sector leadership - Newser
Will Lifecore Biomedical Inc. (LDE) stock keep raising dividendsBreakout Watch & Daily Stock Trend Watchlist - Newser
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Investors to Inquire about Securities Investigation - ACCESS Newswire
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirt - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Investors to Reach Out - ACCESS Newswire
Can Lifecore Biomedical Inc. (LDE) stock deliver strong annual returnsJuly 2025 Analyst Calls & Technical Pattern Based Buy Signals - BỘ NỘI VỤ
How sustainable is Lifecore Biomedical Inc. stock dividend payoutEarnings Growth Report & Technical Buy Zone Confirmations - moha.gov.vn
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Stockholders to Reach Out - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Stockholders to Connect - ACCESS Newswire
How Recent Developments Are Rewriting the Story for Lifecore Biomedical - Yahoo Finance
Precision Trading with Lifecore Biomedical Inc. (LFCR) Risk Zones - news.stocktradersdaily.com
Lifecore Biomedical (LFCR) Price Target Decreased by 12.50% to 8.92 - MSN
How to interpret RSI for Lifecore Biomedical Inc. stockStop Loss & Fast Gaining Stock Strategy Reports - newser.com
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Lifecore Biomedical at Stephens Annual Investment Conference: Strategic Growth Path By Investing.com - Investing.com Canada
Can Lifecore Biomedical Inc. stock surprise with earnings upsideQuarterly Performance Summary & AI Powered Buy and Sell Recommendations - newser.com
Will Lifecore Biomedical Inc. stock benefit from green energy trendsProfit Target & Daily Oversold Stock Bounce Ideas - newser.com
Is Lifecore Biomedical Inc. stock ready for breakoutStop Loss & Short-Term High Return Strategies - newser.com
What candlestick patterns are forming on Lifecore Biomedical Inc.July 2025 Selloffs & Safe Entry Momentum Tips - newser.com
Should I hold or sell Lifecore Biomedical Inc. stock in 2025July 2025 Recap & Capital Protection Trade Alerts - newser.com
How Lifecore Biomedical Inc. stock benefits from strong dollarMarket Rally & Expert-Curated Trade Recommendations - newser.com
Why pension funds invest in Lifecore Biomedical Inc. (LDE) stockBull Run & Technical Confirmation Trade Alerts - newser.com
Lifecore Biomedical at Jefferies London: Strategic Growth Unveiled By Investing.com - Investing.com India
Lifecore Biomedical Inc (LFCR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.48%
0.09%
자본화:
|
볼륨(24시간):